Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis

Frontiers in Immunology

Yingying Han²  Lushan Peng²  Dan Wang²  Tao Huang²  Xiaoyun He³  Junpu Wang⁴  Chunlin Ou⁵ 

[1] Department of Pathology, School of Basic Medicine, Central South University, Changsha, China;Department of Pathology, Xiangya Hospital, Central South University, Changsha, China;Department of Ultrasound Imaging, Xiangya Hospital, Central South University, Changsha, China;Key Laboratory of Hunan Province in Neurodegenerative Disorders, Xiangya Hospital, Central South University, Changsha, China;National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China;

关键词: cancer-associated fibroblasts;    exosomes;    metastasis;    immune response;    biomarkers;    therapy;   

DOI  :  10.3389/fimmu.2021.795372

来源: DOAJ

【 摘 要 】

Cancer-associated fibroblasts (CAFs) are the most important component of the stromal cell population in the tumor microenvironment and play an irreplaceable role in oncogenesis and cancer progression. Exosomes, a class of small extracellular vesicles, can transfer biological information (e.g., proteins, nucleic acids, and metabolites as messengers) from secreting cells to target recipient cells, thereby affecting the progression of human diseases, including cancers. Recent studies revealed that CAF-derived exosomes play a crucial part in tumorigenesis, tumor cell proliferation, metastasis, drug resistance, and the immune response. Moreover, aberrant expression of CAF-derived exosomal noncoding RNAs and proteins strongly correlates with clinical pathological characterizations of cancer patients. Gaining deeper insight into the participation of CAF-derived exosomes in tumorigenesis may lead to novel diagnostic biomarkers and therapeutic targets in human cancers.

【 授权许可】

Unknown